Risk for Affective, Behavioral Disorders Increased in Children After mTBI

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 25, 2024 -- The risk for a new affective or behavioral disorder is increased in children up to four years after sustaining mild traumatic brain injury (mTBI), according to a study published online Jan. 25 in Pediatrics.

Richard L. Delmonico, Ph.D., from Kaiser Permanente Vallejo Medical Center in California, and colleagues conducted a cohort study of mTBI cases (17 years of age and younger; diagnosed from 2000 to 2014) and matched controls within an integrated health care system. The analyses included 18,917 cases and 37,834 controls, randomly selected and matched for age, sex, race/ethnicity, and date of medical visit.

The researchers found that across the first three years after injury, adjusted risks for affective disorders were significantly higher for the mTBI group, especially during the second year (34 percent increase in risk). At years 2 and 4, the adjusted risks for behavioral disorders were significant, with up to a 37 percent increase in risk. The risk for postinjury affective and behavioral disorders was highest among 10- to 13-year-old patients.

"Sustaining mTBI significantly increased the risk of having a new affective or behavioral disorder up to four years after injury," the authors write. "Initial and ongoing screening for affective and behavior disorders after mTBI in children and adolescents can identify persistent conditions that may pose barriers to recovery."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords